HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

Niacin for CVD prevention: no reason to use it given proven options, says the poster

Louis Nervegna · Sep 19, 2026 · ♥ 21 reactions · 11 comments · original Facebook post
PCSK9, ezetimibe & newer drugsLp(a)Statins
AI summary & key facts

The poster gives his opinion that niacin is only better than nothing and no longer worth taking for cardiovascular prevention given proven alternatives. He would never combine it with high-dose statins, citing two large trials with no added benefit and more side effects, and no longer sees a role in high Lp(a) after the HORIZON trial failure.

Some people have asked for my opinion on niacin as a preventative/treatment for CVD.

Here it is:

If my choice were between doing nothing at all verses taking niacin, then I would take niacin.

But given how many proven options there now are, I no longer see any reason why I would take niacin to prevent CVD. The evidence is just not strong enough to justify taking it in place of proven treatments.

And I definitely would never combine niacin with high dose statins, because two large well-done trials showed that it added no benefit, but did increase side effects. When both trials were combined in meta-analysis, there was a small increase in deaths in the group taking niacin along with high dose statins, compared to high dose statins alone.

I used to think that there might still be a use case for niacin in people with high Lp(a). But given the recent failure of the HORIZON trial, I no longer think this.

The only use case I can still see for niacin in CVD is in people who refuse to take any pharmaceuticals at all. In that situation, I think it is better than doing nothing. That’s my opinion.

#niacinHD #horizonHD #lpaHD

Research cited

← newer: Stuart Phillips: protein past 1.6 g/kg adds little, and longolder: Video on the history of the first CT scan in 1971 →